What price for blood pressure control?

Journal of Clinical Hypertension

Volumn 11, Issue 10, 2009, Pages 537-539

  Textor, Stephen C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; NORADRENALIN;

BLOOD PRESSURE REGULATION; CAROTID SINUS PRESSORECEPTOR; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG APPROVAL; DRUG COST; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EDITORIAL; ELECTRODE; ELECTROSTIMULATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RECEPTOR UPREGULATION; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

BLOOD PRESSURE; CAROTID BODY; COST-BENEFIT ANALYSIS; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; HUMANS; HYPERTENSION; MARKOV CHAINS; QUALITY-ADJUSTED LIFE YEARS;

EID: 70350273068     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00193.x     Document Type: Editorial

References (7)

1. Calhoun DA, Jones D, Textor SC, et al. Resistant hypertension: diagnosis, evaluation and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for high blood pressure research. Circulation. 2008;117:e510-e526.
2. Hajjar I, Kotchen TA. Trends in the prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
3. Doumas M, Guo D, Papademetriou V. Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions. Expert Opin Ther Targets. 2009;13:413-425.
4. Lohmeier TE, Hildebrandt DA, Warren S, et al. Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol. 2005;288(4):R828-R836.
5. Mohaupt MG, Schmidli J, Luft FC. Management of uncontrollable hypertension with a carotid sinus stimulation device. Hypertension. 2007;50:825-828.
6. Scheffers IJM, Kroon AA, Tordoir JHM, et al. Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension. Expert Rev Med Devices. 2008;5:33-39.
7. Young K, Teeters J, Benesch C, et al. Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator. J Clin Hypertens (Greenwich). 2009;11:555-563.